- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03132844
Epidemiological Study on the Vaccination Coverage of the Population Aged 75 Years and Over in Picardy. According to the Study of 200 Patients Followed by General Practitioners of the Somme in 2016. (PICARVAC)
October 4, 2018 updated by: Centre Hospitalier Universitaire, Amiens
In France, the vaccination coverage of seniors is clearly deficient.
It seems to be a cultural specificity, dating back more than 100 years, and which does not exist in Scandinavia, nor in much of the Anglo-Saxon world.
Only influenza vaccination is a success for seniors.
The high public health council sets the objective of immunization coverage in patients over 65 years of age to 80% whether or not the patient is benefiting from an exonerative ALD.
The data collections carried out with the various pension funds objective have a lower immunization coverage with a rate ranging from 48.8 to 64%.
Thus any medical consultation should be an opportunity to update the vaccination schedule of adults and the elderly.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Picardie
-
Amiens, Picardie, France, 80054
- CHU Amiens Picardie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
75 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients over 75 years of general practice in the Somme
Description
Inclusion Criteria:
- Man or woman,> 75 years old.
- Seen in consultation at the doctor's office
- In 2016.
Exclusion Criteria:
- Patient seen during a home visit.
- Patient resident in EHPAD.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analysis of the rate of patients over 75 years old followed in general medicine in the Somme, with an up-to-date immunization schedule
Time Frame: 5 months
|
Analysis of the rate of patients over 75 years old followed in general medicine in the Somme, with an up-to-date immunization schedule
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 17, 2017
Primary Completion (Actual)
March 10, 2018
Study Completion (Actual)
March 10, 2018
Study Registration Dates
First Submitted
April 14, 2017
First Submitted That Met QC Criteria
April 25, 2017
First Posted (Actual)
April 28, 2017
Study Record Updates
Last Update Posted (Actual)
October 5, 2018
Last Update Submitted That Met QC Criteria
October 4, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- RNI2016-38 Dr Deschasse
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elderly
-
University of Rome Foro ItalicoEnrolling by invitationAging | Elderly | Frail Elderly | Aging Frailty | Sarcopenia in ElderlyItaly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
University of ThessalyCompletedFunctionality, Falls, Elderly, Fall Prevention, Exercise Elderly, Assessment, Rehabilitation, Community-DwellingGreece
-
Indian Council of Medical ResearchSt Johns Medical College Hospital, Bangalore, IndiaRecruiting
-
Burdur Mehmet Akif Ersoy UniversityPamukkale UniversityCompleted
-
Hospital Israelita Albert EinsteinConselho Nacional de Desenvolvimento Científico e Tecnológico; Paulo de Tarso...Completed
-
Istanbul Medipol University HospitalCompleted
-
Seoul National University HospitalCompleted
-
Purdue UniversityCompleted
Clinical Trials on Analysis records of patients over 75 years of age
-
HJ23Joan XXIII University HospitalCompletedColorectal Cancer | Colorectal Cancer in Patients Under 50 Years of AgeSpain
-
Sahmyook UniversityCompletedMild Cognitive Impairment | Dual TaskKorea, Republic of
-
Plovdiv Medical UniversityDemocritus University of ThraceEnrolling by invitationVision ScreeningBulgaria
-
China Academy of Chinese Medical SciencesZhengzhou Children's Hospital, China; Qilu Children's Hospital of Shandong... and other collaboratorsUnknownUpper Respiratory Tract Infection | Acute Tracheobronchitis
-
Andros Day Surgery ClinicCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompletedChildhood Cancer | Multiple DiseasesUnited States
-
Changhai HospitalCompletedPancreatic Stenting | Pancreatic Stent DisplacementChina
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2 | Adverse Effects | Safety | VaccinesSouth Korea
-
University Hospital, MontpellierNeurogenetic department, CHU Bordeaux; Genetic Department , CHU Montpellier-France and other collaboratorsUnknown